These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32890553)

  • 1. Inhibition of growth and lung metastasis of breast cancer by tumor-homing triple-bioresponsive nanotherapeutics.
    Zhang X; Huang Y; Song H; Canup BSB; Gou S; She Z; Dai F; Ke B; Xiao B
    J Control Release; 2020 Dec; 328():454-469. PubMed ID: 32890553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quadruple-responsive nanoparticle-mediated targeted combination chemotherapy for metastatic breast cancer.
    Huang Y; Xie D; Gou S; Canup BSB; Zhang G; Dai F; Li C; Xiao B
    Nanoscale; 2021 Mar; 13(11):5765-5779. PubMed ID: 33704300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway.
    Li J; Zhang J; Wang Y; Liang X; Wusiman Z; Yin Y; Shen Q
    Int J Pharm; 2017 May; 523(1):300-309. PubMed ID: 28336457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231).
    Balakrishnan S; Mukherjee S; Das S; Bhat FA; Raja Singh P; Patra CR; Arunakaran J
    Cell Biochem Funct; 2017 Jun; 35(4):217-231. PubMed ID: 28498520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved therapeutic efficacy of quercetin-loaded polymeric nanoparticles on triple-negative breast cancer by inhibiting uPA.
    Zhou Y; Chen D; Xue G; Yu S; Yuan C; Huang M; Jiang L
    RSC Adv; 2020 Sep; 10(57):34517-34526. PubMed ID: 35514369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition.
    Zhang T; Liu H; Li Y; Li C; Wan G; Chen B; Li C; Wang Y
    Acta Biomater; 2019 Nov; 99():412-425. PubMed ID: 31494294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing Interstitial Fluid Pressure and Inhibiting Pulmonary Metastasis of Breast Cancer by Gelatin Modified Cationic Lipid Nanoparticles.
    Gao X; Zhang J; Huang Z; Zuo T; Lu Q; Wu G; Shen Q
    ACS Appl Mater Interfaces; 2017 Sep; 9(35):29457-29468. PubMed ID: 28799743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
    Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
    Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors.
    Luo G; Yu X; Jin C; Yang F; Fu D; Long J; Xu J; Zhan C; Lu W
    Int J Pharm; 2010 Jan; 385(1-2):150-6. PubMed ID: 19825404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyethyleneimine- -Tocopherol Hydrogen Succinate/Hyaluronic Acid-Quercetin (PEI-TOS/HA-QU) Core-Shell Micelles Delivering Paclitaxel for Combinatorial Treatment of MDR Breast Cancer.
    Qian J; Liu S; Yang T; Xiao Y; Sun J; Zhao J; Zhang Z; Xie Y
    J Biomed Nanotechnol; 2021 Mar; 17(3):382-398. PubMed ID: 33875073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
    Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
    Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Platycodonis Radix-Curcumae Rhizoma on oral nanoparticle uptake and in vitro inhibition against breast cancer metastasis].
    Shi JP; Zhang RG; Gu XY; Sun YW; Feng NP; Liu Y
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2419-2425. PubMed ID: 37282871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer.
    Balakrishnan S; Bhat FA; Raja Singh P; Mukherjee S; Elumalai P; Das S; Patra CR; Arunakaran J
    Cell Prolif; 2016 Dec; 49(6):678-697. PubMed ID: 27641938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis.
    Gou S; Huang Y; Wan Y; Ma Y; Zhou X; Tong X; Huang J; Kang Y; Pan G; Dai F; Xiao B
    Biomaterials; 2019 Aug; 212():39-54. PubMed ID: 31103945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembly of Hyaluronic Acid-Cu-Quercetin flavonoid nanoparticles: synergistic chemotherapy to target tumors.
    Yue H; Zhao X; Yong Q; Shi M; Jiang X; Zhang Y; Yu X
    PeerJ; 2023; 11():e15942. PubMed ID: 37663303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augment the efficacy of eradicating metastatic lesions and tumor proliferation in breast cancer by honokiol-loaded pH-sensitive targeted lipid nanoparticles.
    Zhang H; Li J; Yuan R; Li Y; Zhang Y; Hu X; Qu J; Chen Y; Wang Z; Xia M; Wang D
    Colloids Surf B Biointerfaces; 2021 Nov; 207():112008. PubMed ID: 34333303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
    Liu Y; Xie X; Hou X; Shen J; Shi J; Chen H; He Y; Wang Z; Feng N
    J Nanobiotechnology; 2020 May; 18(1):83. PubMed ID: 32473632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating metastatic triple negative breast cancer with CD44/neuropilin dual molecular targets of multifunctional nanoparticles.
    Liang DS; Zhang WJ; Wang AT; Su HT; Zhong HJ; Qi XR
    Biomaterials; 2017 Aug; 137():23-36. PubMed ID: 28528300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.